The deal will help the Finnish diagnostics company expand its offerings of PCR-based gastrointestinal diagnostic tests.
CeMeT, short for Center for Metagenomics, was founded in 2014 as a spinout from genetic diagnostics firm CeGaT in Tübingen.
A study of gut microbes in infants with or without necrotizing enterocolitis points to a uropathogenic Escherichia coli association in infected preterm infants
Under a four-year agreement, Unilabs will offer Mobidiag's Amplidiag products in Sweden and Norway.
Using Quanterix's Simoa technology, the group developed assays to detect C. diff toxins with a high degree of sensitivity and specificity.
Two new projects announced last week will showcase organ-on-chip technology developed at the Wyss Institute.
The scientists will use gut-on-a-chip technology to develop probiotics that can sense and respond to pathogenic microbes that have made their way into a person's GI system.
The company has also received approvals for various molecular diagnostics in the US and Canada in recent months.
The product introduction comes about two years after the company merged with AmpliDiag and Genewave.
A team tracking gut microbial communities over time in premature infants found distinct microbial dynamics related to the timing of necrotizing enterocolitis onset.
In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.
Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.
The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.
Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.